Table 3.
Univariate analysis | Multivariate analysis (Backward: LR) | |||||
---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | |
Age group (years) | ||||||
15–44 | 1 | 1 | ||||
45–64 | 2.645 | 1.239–5.647 | 0.012 | 2.700 | 1.221–5.971 | 0.014 |
≥65 | 2.202 | 1.019–4.759 | 0.045 | 2.138 | 0.956–4.784 | 0.064 |
Gender (woman compared to man) | 1.195 | 0.758–1.885 | 0.443 | – | – | NS |
Education level (per 1 level increase) | 0.969 | 0.805–1.166 | 0.736 | – | – | NS |
Occupation (working actively compared to not working) | 0.913 | 0.589–1.414 | 0.683 | – | – | NS |
Fagerström test score (per 1 score increase) | 0.894 | 0.552– 1.448 | 0.649 | – | – | NS |
Comorbid disease (presence compared to absence) | 1.065 | 0.953–1.190 | 0.264 | – | – | NS |
Started treatment choice | ||||||
cNRT | 1 | |||||
Bupropion | 1.143 | 0.571–2.288 | 0.706 | – | – | NS |
Varenicline | 0.852 | 0.416–1.746 | 0.662 | |||
Adverse reaction (absence compared to presence) | 0.980 | 0.594–1.614 | 0.936 | – | – | NS |
Control visit number (per 1 visit increase) | 1.305 | 1.067–1.596 | 0.009 | – | – | NS |
Treatment adherent (adherent compared to non-adherent) | 1.599 | 1.283–1.993 | 0.001 | 3.231 | 2.036–5.129 | 0.001 |
Backward Stepwise (likelihood ratio): -2LOG likelihood: 416.276. Nagelkerke R. Square: 0.158. Omnibus tests of model coefficients: p=0.000. Durbin-Watson test: 2.20